Literature DB >> 12884097

Usefulness of peak-to-peak pulsatility index in infrainguinal bypass graft surveillance.

Yoshinori Inoue1, Takehisa Iwai.   

Abstract

PURPOSE: We conducted this study to find out whether the peak-to-peak pulsatility index (PPI) predicted graft failure and which factors affected the PPI.
METHODS: Color-duplex sonography was used to take 520 scans of 74 infrainguinal bypasses, 62 of which were femoropopliteal bypasses and 12 of which were femorocrural bypasses. Vessel diameter and velocity waveform were measured in the graft as well as in the proximal and distal arteries.
RESULTS: There were 13 cases of graft failure. The PPI in the mid-graft was significantly different in the normal group (12.30 +/- 8.77) and the graft failure group (4.17 +/- 1.79). A PPI of less than 7.0 in the mid-graft was defined as graft failure, with a sensitivity of 96.0% and a specificity of 77.6%. There was no correlation between the graft diameter and the PPI. The average mode frequency was inversely correlated with the PPI (PPI = 44.8 x Mode F(-1) + 3.50, correlation co-efficient: 0.78).
CONCLUSION: One point measurement of the PPI in the mid-graft could be a simple and useful parameter for diagnosing graft failure, based on our finding that the waveform was very similar in the proximal artery, the entire graft, and the distal artery. PPI was inversely correlated with average mode frequency because reverse flow decreased or diminished when a significant stenosis existed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884097     DOI: 10.1007/s00595-003-2558-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  1 in total

1.  Impact of in vivo ranges of the variances in the flow velocity waveforms and flow split ratio on the hemodynamic effects of the anastomotic cuff at distal end-to-side anastomosis.

Authors:  Hiroshi Mitsuoka; Siro Kitamura; Kunio Kuwahara; Naoki Unno
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.